AMPH vs MET · P/E 12, rev $732.0M vs P/E 13, $52.16B cap
Amphastar P (AMPH) versus MetLife Inc (MET) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
MetLife Inc (MET) is a insurance - life company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
MET does not have a complete income-statement cache yet.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Not investment advice. Open the AMPH and MET stock pages for the full models.
Not investment advice.